• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢综合征:帕金森病的一个重要危险因素。

Metabolic syndrome: an important risk factor for Parkinson's disease.

作者信息

Zhang Pei, Tian Bo

机构信息

Department of Neurobiology, Tongji Medical School, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan, Hubei 430030, China ; Key Laboratory of Neurological Diseases, Ministry of Education, Wuhan, Hubei 430030, China.

出版信息

Oxid Med Cell Longev. 2014;2014:729194. doi: 10.1155/2014/729194. Epub 2014 May 14.

DOI:10.1155/2014/729194
PMID:24955210
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4052080/
Abstract

Metabolic syndrome is becoming commoner due to a rise in obesity rates among adults. Generally speaking, a person with metabolic syndrome is twice as likely to develop cardiovascular disease and five times as likely to develop diabetes as someone without metabolic syndrome. Increasing oxidative stress in metabolic syndrome and Parkinson's disease is mentioned in the comprehensive articles; however, the system review about clear relation between metabolic syndrome and Parkinson's disease is deficient. In this review, we will focus on the analysis that the metabolic syndrome may be a risk factor for Parkinson's disease and the preventions that reduce the incident of Parkinson's disease by regulating the oxidative stress.

摘要

由于成年人肥胖率上升,代谢综合征正变得越来越普遍。一般来说,患有代谢综合征的人患心血管疾病的可能性是没有代谢综合征的人的两倍,患糖尿病的可能性是其五倍。综合文章中提到了代谢综合征和帕金森病中氧化应激的增加;然而,关于代谢综合征与帕金森病之间明确关系的系统综述却很缺乏。在本综述中,我们将重点分析代谢综合征可能是帕金森病的一个危险因素,以及通过调节氧化应激来降低帕金森病发病率的预防措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d27b/4052080/37f6e5fe18a6/OMCL2014-729194.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d27b/4052080/37f6e5fe18a6/OMCL2014-729194.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d27b/4052080/37f6e5fe18a6/OMCL2014-729194.001.jpg

相似文献

1
Metabolic syndrome: an important risk factor for Parkinson's disease.代谢综合征:帕金森病的一个重要危险因素。
Oxid Med Cell Longev. 2014;2014:729194. doi: 10.1155/2014/729194. Epub 2014 May 14.
2
Parkinson's syndrome and Parkinson's disease in mitochondrial disorders.线粒体疾病中的帕金森综合征和帕金森病。
Mov Disord. 2011 Apr;26(5):784-91. doi: 10.1002/mds.23651. Epub 2011 Mar 7.
3
Metabolic syndrome as a risk for Parkinson's disease: A new therapeutic opportunity.代谢综合征作为帕金森病的一个风险因素:一种新的治疗契机。
Brain Behav Immun. 2023 Jul;111:125-126. doi: 10.1016/j.bbi.2023.03.030. Epub 2023 Apr 1.
4
Association of metabolic syndrome with falls in patients with Parkinson's disease.代谢综合征与帕金森病患者跌倒的关联。
Clin Nutr. 2017 Apr;36(2):559-563. doi: 10.1016/j.clnu.2016.02.004. Epub 2016 Feb 11.
5
Metabolic syndrome and dementia associated with Parkinson's disease: impact of age and hypertension.代谢综合征与帕金森病相关痴呆:年龄和高血压的影响
Arq Neuropsiquiatr. 2012 Feb;70(2):114-8. doi: 10.1590/s0004-282x2012000200008.
6
Rotenone Susceptibility Phenotype in Olfactory Derived Patient Cells as a Model of Idiopathic Parkinson's Disease.以嗅觉来源的患者细胞中的鱼藤酮敏感性表型作为特发性帕金森病的模型
PLoS One. 2016 Apr 28;11(4):e0154544. doi: 10.1371/journal.pone.0154544. eCollection 2016.
7
Effect of Metabolic Syndrome on Parkinson's Disease: A Systematic Review.代谢综合征对帕金森病的影响:系统评价。
Clinics (Sao Paulo). 2021 Dec 13;76:e3379. doi: 10.6061/clinics/2021/e3379. eCollection 2021.
8
Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease.衰老黑质中的氧化应激与帕金森病的病因学
Aging Cell. 2019 Dec;18(6):e13031. doi: 10.1111/acel.13031. Epub 2019 Aug 20.
9
Can stress trigger Parkinson's disease?压力会引发帕金森病吗?
J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):878-81. doi: 10.1136/jnnp-2013-305911. Epub 2013 Nov 20.
10
Protective and toxic roles of dopamine in Parkinson's disease.多巴胺在帕金森病中的保护和毒性作用。
J Neurochem. 2014 Jun;129(6):898-915. doi: 10.1111/jnc.12686. Epub 2014 Mar 18.

引用本文的文献

1
Association between metabolic syndrome and the risk of Parkinson's disease: a meta-analysis.代谢综合征与帕金森病风险的关联:一项荟萃分析。
BMC Neurol. 2024 Sep 4;24(1):313. doi: 10.1186/s12883-024-03820-y.
2
Association of metabolic syndrome and its components with Parkinson's disease: a cross-sectional study.代谢综合征及其成分与帕金森病的关联:一项横断面研究。
BMC Endocr Disord. 2024 Jun 19;24(1):92. doi: 10.1186/s12902-024-01623-3.
3
Impaired Remodeling of White Adipose Tissue in Obesity and Aging: From Defective Adipogenesis to Adipose Organ Dysfunction.

本文引用的文献

1
Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson's disease.尿酸及其转基因耗竭调节帕金森病细胞模型中的神经元易损性。
PLoS One. 2012;7(5):e37331. doi: 10.1371/journal.pone.0037331. Epub 2012 May 14.
2
Quercetin and sesamin protect neuronal PC12 cells from high-glucose-induced oxidation, nitrosative stress, and apoptosis.槲皮素和芝麻素可保护神经元 PC12 细胞免受高糖诱导的氧化、硝化应激和凋亡。
Rejuvenation Res. 2012 Jun;15(3):322-33. doi: 10.1089/rej.2011.1242. Epub 2012 Apr 23.
3
Is there anything good in uric acid?
肥胖和衰老中白色脂肪组织重构受损:从脂肪生成缺陷到脂肪组织器官功能障碍。
Cells. 2024 Apr 30;13(9):763. doi: 10.3390/cells13090763.
4
AMPK Signaling Pathway as a Potential Therapeutic Target for Parkinson's Disease.AMPK信号通路作为帕金森病的潜在治疗靶点
Adv Pharm Bull. 2024 Mar;14(1):120-131. doi: 10.34172/apb.2024.013. Epub 2023 Oct 14.
5
PKM2-mediated neuronal hyperglycolysis enhances the risk of Parkinson's disease in diabetic rats.丙酮酸激酶M2介导的神经元糖酵解增强糖尿病大鼠患帕金森病的风险。
J Pharm Anal. 2023 Feb;13(2):187-200. doi: 10.1016/j.jpha.2022.11.006. Epub 2022 Nov 21.
6
Structural features and antioxidant activities of polysaccharides from different parts of var. (Nannf.) L. T. Shen.(南荻)变种(Nannf.)L. T. 沈不同部位多糖的结构特征与抗氧化活性
Front Pharmacol. 2022 Aug 24;13:937581. doi: 10.3389/fphar.2022.937581. eCollection 2022.
7
Probiotics treatment for Parkinson disease: a systematic review and meta-analysis of clinical trials.益生菌治疗帕金森病:临床试验的系统评价和荟萃分析。
Aging (Albany NY). 2022 Sep 9;14(17):7014-7025. doi: 10.18632/aging.204266.
8
Association of Diet and Physical Activity With All-Cause Mortality Among Adults With Parkinson Disease.饮食和身体活动与帕金森病患者全因死亡率的关系。
JAMA Netw Open. 2022 Aug 1;5(8):e2227738. doi: 10.1001/jamanetworkopen.2022.27738.
9
Biological Potential of Polyphenols in the Context of Metabolic Syndrome: An Analysis of Studies on Animal Models.代谢综合征背景下多酚的生物学潜力:动物模型研究分析
Biology (Basel). 2022 Apr 7;11(4):559. doi: 10.3390/biology11040559.
10
Long-Term High-Fat Diet Consumption Depletes Glial Cells and Tyrosine Hydroxylase-Containing Neurons in the Brain of Middle-Aged Rats.长期高脂肪饮食会消耗中年大鼠大脑中的神经胶质细胞和含酪氨酸羟化酶的神经元。
Cells. 2022 Jan 15;11(2):295. doi: 10.3390/cells11020295.
尿酸有益处吗?
QJM. 2011 Dec;104(12):1015-24. doi: 10.1093/qjmed/hcr159. Epub 2011 Sep 9.
4
The role of oxidative stress in the metabolic syndrome.氧化应激在代谢综合征中的作用。
Rev Cardiovasc Med. 2011;12(1):21-9. doi: 10.3909/ricm0555.
5
Molecular hydrogen improves obesity and diabetes by inducing hepatic FGF21 and stimulating energy metabolism in db/db mice.分子氢通过诱导肝 FGF21 并刺激 db/db 小鼠的能量代谢来改善肥胖和糖尿病。
Obesity (Silver Spring). 2011 Jul;19(7):1396-403. doi: 10.1038/oby.2011.6. Epub 2011 Feb 3.
6
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.大麻二酚作为一种新出现的治疗策略,可减轻炎症对氧化应激的影响。
Free Radic Biol Med. 2011 Sep 1;51(5):1054-61. doi: 10.1016/j.freeradbiomed.2011.01.007. Epub 2011 Jan 14.
7
Applications and bioefficacy of the functional food supplement fermented papaya preparation.功能性食品补充剂发酵木瓜制剂的应用和生物功效。
Toxicology. 2010 Nov 28;278(1):6-16. doi: 10.1016/j.tox.2010.09.006. Epub 2010 Sep 24.
8
Recent advances in hydrogen research as a therapeutic medical gas.氢气作为治疗性医疗气体的研究进展。
Free Radic Res. 2010 Sep;44(9):971-82. doi: 10.3109/10715762.2010.500328.
9
Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet.帕金森病动物模型中的神经退行性变因高脂肪饮食而加剧。
Am J Physiol Regul Integr Comp Physiol. 2010 Oct;299(4):R1082-90. doi: 10.1152/ajpregu.00449.2010. Epub 2010 Aug 11.
10
Serum vitamin D and the risk of Parkinson disease.血清维生素D与帕金森病风险
Arch Neurol. 2010 Jul;67(7):808-11. doi: 10.1001/archneurol.2010.120.